ACTIVATED CHARCOAL

ACTIVATED CHARCOAL was reported 1541 times

ACTIVATED CHARCOAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 58 0.8286
1 RADIATION INFLAMMATION 24 0.3000
2 ELECTROCARDIOGRAM U WAVE PRESENT 9 0.1452
3 PRODUCT ADMINISTRATION ISSUE 21 0.1005
4 CANNABIS INTERACTION 1 0.0769
5 EYELID MYOCLONUS 5 0.0500
6 CYTOTOXIC OEDEMA 13 0.0491
7 HYPERDYNAMIC LEFT VENTRICLE 12 0.0488
8 ELECTROCARDIOGRAM P WAVE ABNORMAL 9 0.0367
9 CSF PRESSURE INCREASED 9 0.0338
10 PULMONARY PAIN 88 0.0301
11 AUTOMATISM EPILEPTIC 1 0.0278
12 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
13 CATHETER SITE HYPERSENSITIVITY 1 0.0250
14 MYCOTOXICOSIS 1 0.0222
15 ENZYME INDUCTION 1 0.0208
16 BLINDNESS CORTICAL 10 0.0204
17 GENITAL ULCERATION 15 0.0195
18 HEPATIC ISCHAEMIA 6 0.0193
19 OSTEOSARCOMA RECURRENT 1 0.0167
20 RETINAL ISCHAEMIA 10 0.0164
21 TONSILLAR ERYTHEMA 1 0.0152
22 TICK-BORNE FEVER 1 0.0149
23 ELECTROCARDIOGRAM QT INTERVAL 2 0.0139
24 VASOPLEGIA SYNDROME 20 0.0122
25 COLOUR BLINDNESS 10 0.0109
26 NECROSIS ISCHAEMIC 5 0.0108
27 GENITAL PAIN 16 0.0108
28 PERIPHERAL PULSE DECREASED 1 0.0103
29 CRANIAL NERVE INJURY 1 0.0103
30 CARDIAC INDEX DECREASED 1 0.0097
31 MANUFACTURING PRODUCTION ISSUE 1 0.0096
32 OPTIC NERVE INJURY 10 0.0086
33 OPTIC NERVE INFARCTION 1 0.0085
34 EMBOLISM ARTERIAL 10 0.0083
35 OPTIC ATROPHY 13 0.0080
36 COMPARTMENT SYNDROME 20 0.0077
37 VASCULAR RESISTANCE SYSTEMIC DECREASED 1 0.0075
38 BEZOAR 10 0.0072
39 COMA SCALE ABNORMAL 21 0.0072
40 PH BODY FLUID ABNORMAL 1 0.0072
41 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 13 0.0066
42 CHRONIC TONSILLITIS 1 0.0065
43 OESOPHAGEAL ATRESIA 4 0.0064
44 SERUM SEROTONIN DECREASED 1 0.0063
45 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 4 0.0062
46 BLOOD LACTIC ACID DECREASED 1 0.0058
47 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 1 0.0057
48 BIOPSY SKIN 1 0.0056
49 PORTAL VENOUS GAS 2 0.0055
50 SKIN TURGOR DECREASED 2 0.0052
51 ANION GAP 3 0.0047
52 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 24 0.0047
53 EXPOSURE VIA INHALATION 1 0.0046
54 PNEUMONIA STREPTOCOCCAL 5 0.0046
55 PULSE ABSENT 21 0.0044
56 RESPIRATORY FATIGUE 1 0.0043
57 DERMATITIS HERPETIFORMIS 1 0.0041
58 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 9 0.0041
59 ELECTROCARDIOGRAM T WAVE INVERSION 9 0.0041
60 CEREBRAL VASOCONSTRICTION 3 0.0041
61 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0040
62 OBESITY 59 0.0037
63 DISTRIBUTIVE SHOCK 8 0.0035
64 METAL POISONING 2 0.0034
65 FOOD POISONING 18 0.0034
66 LUNG INJURY 1 0.0033
67 GASTRIC HYPOMOTILITY 1 0.0033
68 FEEDING TUBE COMPLICATION 1 0.0032
69 KNEE ARTHROPLASTY 67 0.0032
70 OESOPHAGEAL FISTULA 1 0.0031
71 TRACHEO-OESOPHAGEAL FISTULA 2 0.0031
72 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 2 0.0031
73 INFLAMMATION OF WOUND 1 0.0030
74 CARDIOGENIC SHOCK 42 0.0029
75 PANCREATIC NECROSIS 1 0.0029
76 PNEUMONITIS CHEMICAL 1 0.0029
77 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
78 MECONIUM IN AMNIOTIC FLUID 1 0.0028
79 TRACHEAL HAEMORRHAGE 1 0.0028
80 FOREIGN BODY ASPIRATION 2 0.0028
81 GRANDIOSITY 1 0.0027
82 CARDIAC ASSISTANCE DEVICE USER 1 0.0027
83 HEPATIC INFARCTION 1 0.0027
84 AREFLEXIA 7 0.0026
85 SPLENIC ABSCESS 1 0.0025
86 REACTION TO COLOURING 1 0.0024
87 HYPERAMMONAEMIA 12 0.0024
88 CANDIDA TEST POSITIVE 1 0.0024
89 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
90 INTESTINAL DILATATION 3 0.0022
91 CONGESTIVE HEPATOPATHY 1 0.0022
92 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
93 ISCHAEMIA 10 0.0022
94 PANCREATITIS HAEMORRHAGIC 1 0.0022
95 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
96 SCHIZOPHRENIA 24 0.0020
97 LOWER RESPIRATORY TRACT INFECTION 88 0.0019
98 HYPOPERFUSION 2 0.0019
99 COLLAGEN DISORDER 1 0.0017
100 DOSE CALCULATION ERROR 1 0.0017
101 ENGRAFTMENT SYNDROME 1 0.0017
102 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
103 BRONCHIAL HYPERREACTIVITY 2 0.0017
104 VENTRICULAR ARRHYTHMIA 6 0.0016
105 GASTROINTESTINAL PAIN 18 0.0016
106 SITTING DISABILITY 1 0.0016
107 INTENTIONAL OVERDOSE 104 0.0016
108 BRAIN DEATH 5 0.0016
109 HEPATIC NECROSIS 6 0.0016
110 ARTHROPATHY 87 0.0016
111 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
112 ANOXIC ENCEPHALOPATHY 1 0.0016
113 ILEUS 19 0.0015
114 MULTI-ORGAN DISORDER 3 0.0015
115 SINGLE FUNCTIONAL KIDNEY 1 0.0015
116 ANURIA 13 0.0015
117 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
118 CRANIAL NERVE DISORDER 1 0.0014
119 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
120 LACTIC ACIDOSIS 46 0.0014
121 EYE ROLLING 1 0.0014
122 SHOCK 32 0.0014
123 OROMANDIBULAR DYSTONIA 1 0.0014
124 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
125 BRAIN STEM SYNDROME 1 0.0013
126 GASTROINTESTINAL SURGERY 1 0.0013
127 HYPOTHERMIA 13 0.0013
128 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1 0.0013
129 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 1 0.0013
130 ELECTROMECHANICAL DISSOCIATION 1 0.0013
131 RETICULOCYTE COUNT INCREASED 1 0.0012
132 BASAL GANGLIA HAEMORRHAGE 1 0.0012
133 DYSBIOSIS 1 0.0012
134 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
135 EMBOLISM 10 0.0012
136 TROPONIN I INCREASED 2 0.0012
137 TOXIC ENCEPHALOPATHY 6 0.0012
138 HAEMODYNAMIC INSTABILITY 9 0.0012
139 DRUG ABUSE 98 0.0012
140 INTENTIONAL PRODUCT MISUSE 103 0.0012
141 ARTERIAL STENOSIS 1 0.0011
142 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
143 ENTEROCUTANEOUS FISTULA 1 0.0011
144 CARDIOTOXICITY 10 0.0011
145 HYPERLACTACIDAEMIA 3 0.0011
146 BRADYPNOEA 3 0.0011
147 CLONUS 3 0.0011
148 EXTENSOR PLANTAR RESPONSE 1 0.0011
149 METABOLIC ACIDOSIS 33 0.0010
150 SUICIDE ATTEMPT 62 0.0010
151 DUODENAL PERFORATION 1 0.0010
152 MUCOSAL DRYNESS 2 0.0010
153 DILATED CARDIOMYOPATHY 1 0.0010
154 POLYHYDRAMNIOS 1 0.0010
155 MALABSORPTION 5 0.0010
156 SYSTOLIC DYSFUNCTION 1 0.0009
157 BUNDLE BRANCH BLOCK LEFT 4 0.0009
158 MYDRIASIS 12 0.0009
159 VENTRICULAR HYPOKINESIA 3 0.0009
160 BLOOD TESTOSTERONE INCREASED 2 0.0009
161 HAEMORRHAGIC DISORDER 1 0.0009
162 RENAL TUBULAR NECROSIS 9 0.0009
163 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
164 SINUS TACHYCARDIA 13 0.0009
165 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
166 VENTRICULAR FIBRILLATION 10 0.0009
167 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
168 TORSADE DE POINTES 7 0.0009
169 MYOCARDIAL INJURY 1 0.0009
170 BLOODY DISCHARGE 1 0.0009
171 CARBON DIOXIDE DECREASED 1 0.0009
172 FLAT AFFECT 2 0.0009
173 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
174 CIRCULATORY COLLAPSE 14 0.0008
175 TOXICITY TO VARIOUS AGENTS 137 0.0008
176 PANCREATIC NEOPLASM 1 0.0008
177 FISTULA DISCHARGE 1 0.0008
178 COMPLETED SUICIDE 66 0.0008
179 OVERDOSE 170 0.0008
180 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
181 ACIDOSIS 6 0.0008
182 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
183 HYPERKALAEMIA 27 0.0008
184 TONIC CLONIC MOVEMENTS 1 0.0008
185 CARDIOPULMONARY FAILURE 3 0.0008
186 DRUG CLEARANCE DECREASED 1 0.0008
187 RESPIRATORY ACIDOSIS 3 0.0008
188 NYSTAGMUS 4 0.0008
189 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
190 ANION GAP INCREASED 1 0.0007
191 PRODUCT ADMINISTRATION ERROR 15 0.0007
192 POISONING DELIBERATE 7 0.0007
193 TACHYPNOEA 10 0.0007
194 ISCHAEMIC HEPATITIS 1 0.0007
195 RHONCHI 1 0.0007
196 SINUS BRADYCARDIA 7 0.0007
197 ORAL PAIN 16 0.0007
198 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
199 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
200 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
201 GLUTEN SENSITIVITY 1 0.0007
202 PNEUMATOSIS INTESTINALIS 2 0.0007
203 IRRITABLE BOWEL SYNDROME 15 0.0007
204 HAEMORRHAGE IN PREGNANCY 1 0.0007
205 INVESTIGATION ABNORMAL 1 0.0007
206 COMA 33 0.0007
207 NODAL RHYTHM 1 0.0007
208 BRADYCARDIA 36 0.0007
209 RHABDOMYOLYSIS 28 0.0007
210 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
211 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
212 MIOSIS 5 0.0006
213 AORTIC VALVE DISEASE 1 0.0006
214 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
215 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
216 MUCOSAL INFLAMMATION 16 0.0006
217 LUNG NEOPLASM MALIGNANT 25 0.0006
218 MULTIPLE DRUG OVERDOSE 3 0.0006
219 DRUG LEVEL INCREASED 10 0.0006
220 HYPERNATRAEMIA 3 0.0006
221 GASTRIC DILATATION 1 0.0006
222 BRAIN INJURY 6 0.0006
223 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
224 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
225 HAEMODIALYSIS 5 0.0006
226 SEIZURE LIKE PHENOMENA 1 0.0006
227 BLOOD PH DECREASED 1 0.0006
228 ACUTE SINUSITIS 1 0.0006
229 SERUM FERRITIN DECREASED 1 0.0006
230 PUPIL FIXED 1 0.0006
231 CEREBRAL INFARCTION 14 0.0006
232 DEMENTIA 16 0.0006
233 HYPOKALAEMIA 26 0.0006
234 CARDIAC ABLATION 1 0.0006
235 LEUKOCYTOSIS 10 0.0006
236 ASPIRATION 6 0.0005
237 CONDUCTION DISORDER 1 0.0005
238 INTESTINAL ISCHAEMIA 3 0.0005
239 DISORGANISED SPEECH 1 0.0005
240 LOBAR PNEUMONIA 1 0.0005
241 COAGULOPATHY 9 0.0005
242 ABDOMINAL DISCOMFORT 90 0.0005
243 CARDIAC ARREST 44 0.0005
244 LIP DISORDER 1 0.0005
245 RHEUMATIC DISORDER 1 0.0005
246 BICYTOPENIA 1 0.0005
247 HYPERAEMIA 1 0.0005
248 INFLAMMATION 26 0.0005
249 ANORECTAL DISORDER 1 0.0005
250 BLOOD POTASSIUM DECREASED 15 0.0005
251 TACHYCARDIA 44 0.0005
252 PERIPHERAL ISCHAEMIA 2 0.0005
253 QUADRIPLEGIA 1 0.0005
254 TONGUE BITING 1 0.0005
255 VENTRICULAR TACHYCARDIA 8 0.0005
256 CAPILLARY LEAK SYNDROME 1 0.0005
257 ACCIDENTAL EXPOSURE 2 0.0005
258 CLOSTRIDIUM TEST POSITIVE 1 0.0005
259 PULMONARY OEDEMA 20 0.0004
260 STATUS EPILEPTICUS 5 0.0004
261 DRUG TOXICITY 6 0.0004
262 PNEUMONIA ASPIRATION 11 0.0004
263 NIGHTMARE 15 0.0004
264 METHAEMOGLOBINAEMIA 1 0.0004
265 HYPERTRANSAMINASAEMIA 3 0.0004
266 BILIRUBIN CONJUGATED INCREASED 1 0.0004
267 PULMONARY INFARCTION 1 0.0004
268 URINE FLOW DECREASED 1 0.0004
269 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
270 HYPOGLYCAEMIA 20 0.0004
271 SLOW SPEECH 1 0.0004
272 ENCEPHALOPATHY 10 0.0004
273 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
274 TACHYARRHYTHMIA 1 0.0004
275 HYPOTENSION 80 0.0004
276 POISONING 5 0.0004
277 VASODILATATION 1 0.0004
278 EXPOSURE VIA INGESTION 1 0.0004
279 MENTAL STATUS CHANGES 11 0.0004
280 BRAIN OEDEMA 5 0.0004
281 AMMONIA INCREASED 2 0.0004
282 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
283 APNOEA 3 0.0004
284 HEPATITIS TOXIC 1 0.0004
285 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
286 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
287 BLOOD LACTIC ACID INCREASED 2 0.0004
288 LUNG OPACITY 1 0.0004
289 MEDICATION ERROR 21 0.0004
290 PROTEIN TOTAL INCREASED 1 0.0004
291 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
292 ANGIOPATHY 2 0.0004
293 PSYCHOMOTOR RETARDATION 1 0.0004
294 NEUTROPHILIA 2 0.0004
295 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
296 GASTROINTESTINAL NECROSIS 1 0.0003
297 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
298 HYPOVOLAEMIA 2 0.0003
299 STRIDOR 1 0.0003
300 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
301 RESPIRATORY DEPRESSION 4 0.0003
302 DIASTOLIC DYSFUNCTION 1 0.0003
303 MULTIPLE-DRUG RESISTANCE 1 0.0003
304 OLIGURIA 2 0.0003
305 HYPOCALCAEMIA 6 0.0003
306 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
307 POLYMYALGIA RHEUMATICA 1 0.0003
308 SUBSTANCE USE DISORDER 1 0.0003
309 SEROTONIN SYNDROME 6 0.0003
310 INFUSION SITE HAEMORRHAGE 1 0.0003
311 SUSPECTED COVID-19 1 0.0003
312 PRODUCT FORMULATION ISSUE 2 0.0003
313 METASTASES TO SPINE 1 0.0003
314 DRUG INTERACTION 47 0.0003
315 PRODUCT DOSE OMISSION ISSUE 87 0.0003
316 HEPATIC CYST 1 0.0003
317 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
318 HEPATIC FIBROSIS 1 0.0003
319 HYPERREFLEXIA 1 0.0003
320 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
321 HEAD DISCOMFORT 5 0.0003
322 LIVER TRANSPLANT 1 0.0003
323 AMYLASE INCREASED 1 0.0003
324 CHRONIC SINUSITIS 1 0.0003
325 HYPERTHERMIA 2 0.0003
326 THYROID MASS 1 0.0003
327 OESOPHAGEAL ULCER 1 0.0003
328 ATRIOVENTRICULAR BLOCK 2 0.0003
329 CERVIX CARCINOMA 1 0.0003
330 WOUND SECRETION 1 0.0003
331 DRUG DEPENDENCE 41 0.0003
332 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
333 AZOTAEMIA 1 0.0003
334 ARTERIOSPASM CORONARY 1 0.0002
335 HOMICIDAL IDEATION 1 0.0002
336 BLINDNESS 10 0.0002
337 THYROID FUNCTION TEST ABNORMAL 1 0.0002
338 CONGESTIVE CARDIOMYOPATHY 1 0.0002
339 HALLUCINATIONS, MIXED 1 0.0002
340 HEPATIC CYTOLYSIS 3 0.0002
341 POOR PERIPHERAL CIRCULATION 1 0.0002
342 PURULENT DISCHARGE 1 0.0002
343 CONDITION AGGRAVATED 70 0.0002
344 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
345 ABDOMINAL ABSCESS 1 0.0002
346 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
347 ILEUS PARALYTIC 1 0.0002
348 CHROMATURIA 5 0.0002
349 LOCALISED OEDEMA 1 0.0002
350 HYPOMAGNESAEMIA 3 0.0002
351 SUSPECTED SUICIDE 1 0.0002
352 HYPOVOLAEMIC SHOCK 1 0.0002
353 RASH 91 0.0002
354 ATELECTASIS 2 0.0002
355 HYPERVOLAEMIA 1 0.0002
356 SMALL FOR DATES BABY 1 0.0002
357 ERYSIPELAS 1 0.0002
358 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
359 UNRESPONSIVE TO STIMULI 5 0.0002
360 TONSILLITIS 1 0.0002
361 CARDIO-RESPIRATORY ARREST 8 0.0002
362 PARTIAL SEIZURES 1 0.0002
363 FOLLICULITIS 2 0.0002
364 ACUTE KIDNEY INJURY 29 0.0002
365 VIROLOGIC FAILURE 1 0.0002
366 FAECES DISCOLOURED 4 0.0002
367 SEPTIC SHOCK 8 0.0002
368 CHOKING SENSATION 1 0.0002
369 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
370 HEPATOTOXICITY 4 0.0002
371 ACUTE PULMONARY OEDEMA 1 0.0002
372 GENERALISED ERYTHEMA 1 0.0002
373 NEUROLOGICAL SYMPTOM 1 0.0002
374 HYPERTONIA 1 0.0002
375 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
376 ENTEROCOLITIS 1 0.0002
377 SEIZURE 20 0.0002
378 DYSKINESIA 7 0.0002
379 METABOLIC DISORDER 1 0.0002
380 ELECTROLYTE IMBALANCE 2 0.0002
381 HYPERTRIGLYCERIDAEMIA 1 0.0002
382 HYPOXIA 6 0.0002
383 MUSCLE RIGIDITY 2 0.0002
384 PROTHROMBIN TIME PROLONGED 1 0.0002
385 ILLNESS 17 0.0002
386 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
387 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
388 SMALL INTESTINAL OBSTRUCTION 2 0.0002
389 GENERALISED OEDEMA 2 0.0002
390 SCOLIOSIS 1 0.0002
391 CONTUSION 15 0.0002
392 THERAPY NON-RESPONDER 7 0.0002
393 OFF LABEL USE 136 0.0002
394 COVID-19 27 0.0002
395 PULMONARY CONGESTION 2 0.0002
396 CORONAVIRUS INFECTION 1 0.0002
397 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
398 POST-TRAUMATIC STRESS DISORDER 1 0.0001
399 COLITIS ISCHAEMIC 1 0.0001
400 THROAT TIGHTNESS 4 0.0001
401 PNEUMONITIS 4 0.0001
402 ACUTE HEPATIC FAILURE 2 0.0001
403 NEPHROTIC SYNDROME 1 0.0001
404 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
405 DROOLING 1 0.0001
406 FORMICATION 1 0.0001
407 PANCYTOPENIA 8 0.0001
408 PULMONARY TOXICITY 1 0.0001
409 RETCHING 3 0.0001
410 PANIC REACTION 1 0.0001
411 DERMATITIS BULLOUS 1 0.0001
412 AGITATION 10 0.0001
413 DUODENAL ULCER PERFORATION 1 0.0001
414 SOMNOLENCE 27 0.0001
415 RASH PAPULAR 3 0.0001
416 TENDON PAIN 1 0.0001
417 SKIN DISCOLOURATION 6 0.0001
418 BRAIN FOG 2 0.0001
419 TRICUSPID VALVE INCOMPETENCE 1 0.0001
420 ATRIAL FLUTTER 1 0.0001
421 PERIPHERAL SWELLING 19 0.0001
422 ASPHYXIA 1 0.0001
423 LIVER INJURY 3 0.0001
424 ESCHERICHIA INFECTION 1 0.0001
425 BLOOD PRESSURE DECREASED 8 0.0001
426 SECOND PRIMARY MALIGNANCY 1 0.0001
427 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
428 FACIAL PARALYSIS 1 0.0001
429 LOSS OF CONSCIOUSNESS 15 0.0001
430 URINE OUTPUT DECREASED 1 0.0001
431 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
432 PRODUCT COMMUNICATION ISSUE 1 0.0001
433 RESPIRATORY RATE INCREASED 1 0.0001
434 ABDOMINAL PAIN 26 0.0001
435 ANAL INCONTINENCE 1 0.0001
436 HEAVY MENSTRUAL BLEEDING 1 0.0001
437 OROPHARYNGEAL DISCOMFORT 1 0.0001
438 TOOTHACHE 2 0.0001
439 GASTROINTESTINAL CARCINOMA 1 0.0001
440 LIP DRY 1 0.0001
441 ACCIDENTAL OVERDOSE 4 0.0001
442 RESPIRATORY DISTRESS 3 0.0001
443 GRAND MAL CONVULSION 1 0.0001
444 HEPATIC ENCEPHALOPATHY 1 0.0001
445 FLANK PAIN 1 0.0001
446 ARTERIOSCLEROSIS 1 0.0001
447 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
448 CONVULSION 6 0.0001
449 VISUAL IMPAIRMENT 13 0.0001
450 EYE INFLAMMATION 1 0.0001
451 ACUTE RESPIRATORY FAILURE 2 0.0001
452 PRESCRIBED OVERDOSE 2 0.0001
453 AUTOIMMUNE DISORDER 1 0.0001
454 VITAMIN D DEFICIENCY 1 0.0001
455 INFLAMMATORY BOWEL DISEASE 1 0.0001
456 VOMITING 48 0.0001
457 COELIAC DISEASE 1 0.0001
458 THERAPY CHANGE 1 0.0001
459 LIGAMENT SPRAIN 1 0.0001
460 RENAL INJURY 3 0.0001
461 BLOOD PRESSURE ABNORMAL 2 0.0001
462 RESPIRATORY DISORDER 3 0.0001
463 FEELING ABNORMAL 24 0.0001
464 SALIVARY HYPERSECRETION 1 0.0001
465 PREMATURE BABY 3 0.0001
466 INITIAL INSOMNIA 1 0.0001
467 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
468 VENTRICULAR EXTRASYSTOLES 1 0.0001
469 TENDERNESS 1 0.0001
470 UNINTENDED PREGNANCY 1 0.0001
471 FULL BLOOD COUNT ABNORMAL 1 0.0001
472 LIVER FUNCTION TEST INCREASED 2 0.0001
473 POOR QUALITY SLEEP 2 0.0001
474 PRODUCT DISPENSING ERROR 2 0.0001
475 PRODUCT PRESCRIBING ISSUE 2 0.0001
476 BLOOD GLUCOSE FLUCTUATION 1 0.0001
477 TRANSAMINASES INCREASED 2 0.0001
478 URINARY RETENTION 3 0.0001
479 NEPHROPATHY TOXIC 1 0.0001
480 FISTULA 1 0.0001
481 EYE INFECTION 1 0.0001
482 FLATULENCE 5 0.0001
483 MYOCARDIAL ISCHAEMIA 1 0.0001
484 DERMATITIS CONTACT 1 0.0001
485 METASTASES TO LUNG 1 0.0001
486 ATAXIA 1 0.0001
487 MYOCLONUS 1 0.0001
488 CEREBRAL HAEMORRHAGE 3 0.0001
489 POLYNEUROPATHY 1 0.0001
490 DRUG INEFFECTIVE 110 0.0001
491 THYROID CANCER 1 0.0001
492 ABDOMINAL PAIN UPPER 17 0.0001
493 HYPERGLYCAEMIA 3 0.0001
494 PRESYNCOPE 2 0.0001
495 CARDIOMEGALY 1 0.0001
496 HYPERCALCAEMIA 1 0.0001
497 HEPATIC FUNCTION ABNORMAL 3 0.0001
498 SECRETION DISCHARGE 1 0.0001
499 DERMATITIS ALLERGIC 1 0.0001
500 CELLULITIS 4 0.0001
501 HYPOPHAGIA 2 0.0001
502 DRUG RESISTANCE 2 0.0001
503 ABDOMINAL DISTENSION 8 0.0001
504 NODULE 1 0.0001
505 PANCREATITIS 4 0.0001
506 ADVERSE REACTION 1 0.0001
507 CARDIAC FAILURE 6 0.0001
508 PRODUCT TASTE ABNORMAL 1 0.0001
509 PALLOR 2 0.0001
510 DRUG INTOLERANCE 7 0.0001
511 SKIN REACTION 1 0.0001
512 HEPATOCELLULAR INJURY 1 0.0001
513 HYPERSOMNIA 2 0.0001
514 LETHARGY 4 0.0001
515 PARAESTHESIA ORAL 1 0.0001
516 FLUID OVERLOAD 1 0.0001
517 RESPIRATORY FAILURE 5 0.0001
518 CARDIOMYOPATHY 1 0.0001
519 GASTROINTESTINAL DISORDER 6 0.0001
520 HAEMORRHAGE INTRACRANIAL 1 0.0001
521 HEPATIC FAILURE 2 0.0001
522 HIP ARTHROPLASTY 1 0.0001
523 THYROID DISORDER 1 0.0001
524 NERVOUS SYSTEM DISORDER 2 0.0001
525 OCULAR HYPERAEMIA 3 0.0001
526 RESPIRATORY TRACT CONGESTION 1 0.0001
527 HALLUCINATION, AUDITORY 1 0.0001
528 THROMBOCYTOPENIA 7 0.0001
529 SENSORY DISTURBANCE 1 0.0001
530 HYPERHIDROSIS 8 0.0001
531 BLOOD POTASSIUM INCREASED 1 0.0001
532 METASTASES TO BONE 1 0.0001
533 EYE DISORDER 2 0.0001
534 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
535 EXPIRED PRODUCT ADMINISTERED 2 0.0001
536 LIP SWELLING 2 0.0001
537 BLOOD UREA INCREASED 1 0.0001
538 FACE OEDEMA 1 0.0001
539 SCAR 1 0.0001
540 HAEMATURIA 2 0.0001
541 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
542 MUSCULOSKELETAL DISCOMFORT 1 0.0001
543 MULTI-ORGAN FAILURE 1 0.0001
544 ORTHOSTATIC HYPOTENSION 1 0.0001
545 NEUROTOXICITY 1 0.0001
546 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
547 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
548 DRUG ERUPTION 1 0.0001
549 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
550 THIRST 1 0.0001
551 RASH PRURITIC 3 0.0001
552 DIARRHOEA 35 0.0001
553 THINKING ABNORMAL 1 0.0001
554 OXYGEN SATURATION DECREASED 3 0.0001
555 UNEVALUABLE EVENT 4 0.0001
556 GASTRIC ULCER 1 0.0001
557 FEELING JITTERY 1 0.0001
558 MALAISE 23 0.0001
559 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
560 HYPERTENSION 11 0.0001
561 ERUCTATION 1 0.0001
562 DYSTONIA 1 0.0001
563 EAR PAIN 1 0.0001
564 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
565 HAEMORRHOIDS 1 0.0001
566 CATARACT 3 0.0001
567 PRESCRIBED UNDERDOSE 1 0.0001
568 PRODUCT PHYSICAL ISSUE 1 0.0000
569 INTENTIONAL SELF-INJURY 1 0.0000
570 STOMATITIS 3 0.0000
571 FEEDING DISORDER 1 0.0000
572 DRY MOUTH 4 0.0000
573 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
574 BODY TEMPERATURE INCREASED 1 0.0000
575 RIB FRACTURE 1 0.0000
576 PERITONITIS 1 0.0000
577 EXPOSURE DURING PREGNANCY 3 0.0000
578 PULMONARY HYPERTENSION 1 0.0000
579 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
580 RENAL IMPAIRMENT 4 0.0000
581 MOUTH ULCERATION 1 0.0000
582 MENTAL DISORDER 2 0.0000
583 BLOOD CREATININE INCREASED 3 0.0000
584 SUICIDAL IDEATION 4 0.0000
585 TINNITUS 2 0.0000
586 MUSCLE TWITCHING 1 0.0000
587 ARRHYTHMIA 2 0.0000
588 LOCALISED INFECTION 1 0.0000
589 MENTAL IMPAIRMENT 1 0.0000
590 EXTRAPYRAMIDAL DISORDER 1 0.0000
591 LEUKOPENIA 2 0.0000
592 CARDIOVASCULAR DISORDER 1 0.0000
593 THERAPY CESSATION 2 0.0000
594 ANAPHYLACTIC SHOCK 1 0.0000
595 SKIN ULCER 1 0.0000
596 HAEMATOMA 1 0.0000
597 SPEECH DISORDER 2 0.0000
598 JOINT STIFFNESS 1 0.0000
599 THROMBOSIS 3 0.0000
600 FEAR 1 0.0000
601 JAUNDICE 1 0.0000
602 BLOOD BILIRUBIN INCREASED 1 0.0000
603 MOOD ALTERED 1 0.0000
604 TREATMENT NONCOMPLIANCE 2 0.0000
605 RESPIRATORY ARREST 1 0.0000
606 TREATMENT FAILURE 3 0.0000
607 TREMOR 6 0.0000
608 DIZZINESS 18 0.0000
609 DIVERTICULITIS 1 0.0000
610 FEELING COLD 1 0.0000
611 SEPSIS 4 0.0000
612 NECK PAIN 2 0.0000
613 INTENTIONAL DOSE OMISSION 1 0.0000
614 ANGINA PECTORIS 1 0.0000
615 LIVER FUNCTION TEST ABNORMAL 1 0.0000
616 DYSSTASIA 1 0.0000
617 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
618 BONE PAIN 2 0.0000
619 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
620 HYPOAESTHESIA 5 0.0000
621 IRRITABILITY 2 0.0000
622 APHASIA 1 0.0000
623 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
624 INJECTION SITE RASH 1 0.0000
625 OROPHARYNGEAL PAIN 3 0.0000
626 HYPERSENSITIVITY 6 0.0000
627 SWELLING 3 0.0000
628 SWOLLEN TONGUE 1 0.0000
629 PARAESTHESIA 5 0.0000
630 NEUROPATHY PERIPHERAL 3 0.0000
631 ANAEMIA 6 0.0000
632 MIGRAINE 3 0.0000
633 MOVEMENT DISORDER 1 0.0000
634 NIGHT SWEATS 1 0.0000
635 PNEUMONIA 10 0.0000
636 DEEP VEIN THROMBOSIS 2 0.0000
637 CHOLELITHIASIS 1 0.0000
638 STAPHYLOCOCCAL INFECTION 1 0.0000
639 BACK PAIN 7 0.0000
640 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
641 ANGER 1 0.0000
642 CHEST DISCOMFORT 3 0.0000
643 DELIRIUM 1 0.0000
644 HEART RATE DECREASED 1 0.0000
645 SLEEP DISORDER 2 0.0000
646 LYMPHADENOPATHY 1 0.0000
647 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
648 ANXIETY 8 0.0000
649 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
650 MOBILITY DECREASED 2 0.0000
651 CRYING 1 0.0000
652 PANIC ATTACK 1 0.0000
653 NASOPHARYNGITIS 5 0.0000
654 EYE SWELLING 1 0.0000
655 PRODUCT USE ISSUE 5 0.0000
656 DYSARTHRIA 1 0.0000
657 HALLUCINATION 2 0.0000
658 INTESTINAL OBSTRUCTION 1 0.0000
659 BLOOD PRESSURE INCREASED 4 0.0000
660 PYREXIA 9 0.0000
661 ABNORMAL BEHAVIOUR 1 0.0000
662 DISORIENTATION 1 0.0000
663 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
664 CONFUSIONAL STATE 4 0.0000
665 WITHDRAWAL SYNDROME 1 0.0000
666 RECTAL HAEMORRHAGE 1 0.0000
667 CONSTIPATION 5 0.0000
668 DRUG WITHDRAWAL SYNDROME 2 0.0000
669 RENAL FAILURE 3 0.0000
670 THROAT IRRITATION 1 0.0000
671 NO ADVERSE EVENT 4 0.0000
672 DEPRESSION 5 0.0000
673 DECREASED APPETITE 5 0.0000
674 BLOOD CHOLESTEROL INCREASED 1 0.0000
675 COGNITIVE DISORDER 1 0.0000
676 DYSPHAGIA 2 0.0000
677 RENAL CANCER 1 0.0000
678 PRODUCTIVE COUGH 1 0.0000
679 RASH ERYTHEMATOUS 1 0.0000
680 LUNG DISORDER 1 0.0000
681 HEART RATE INCREASED 2 0.0000
682 SYNCOPE 2 0.0000
683 AGGRESSION 1 0.0000
684 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
685 DYSPNOEA 11 0.0000
686 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
687 NERVOUSNESS 1 0.0000
688 MUSCULOSKELETAL PAIN 1 0.0000
689 NAUSEA 15 0.0000
690 INSOMNIA 5 0.0000
691 DISTURBANCE IN ATTENTION 1 0.0000
692 ANAPHYLACTIC REACTION 1 0.0000
693 WEIGHT DECREASED 5 0.0000
694 BLISTER 1 0.0000
695 HYPONATRAEMIA 1 0.0000
696 EYE PAIN 1 0.0000
697 ASTHMA 2 0.0000
698 MUSCULAR WEAKNESS 2 0.0000
699 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
700 PALPITATIONS 2 0.0000
701 CHILLS 2 0.0000
702 BLADDER CANCER 1 0.0000
703 DISEASE PROGRESSION 2 0.0000
704 ILL-DEFINED DISORDER 1 0.0000
705 PLEURAL EFFUSION 1 0.0000
706 VERTIGO 1 0.0000
707 FEELING HOT 1 0.0000
708 CHEST PAIN 3 0.0000
709 HEADACHE 10 0.0000
710 RHINORRHOEA 1 0.0000
711 SWELLING FACE 1 0.0000
712 INFUSION RELATED REACTION 1 0.0000
713 FEBRILE NEUTROPENIA 1 0.0000
714 DEHYDRATION 2 0.0000
715 NEUTROPENIA 2 0.0000
716 ERYTHEMA 3 0.0000
717 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
718 COUGH 4 0.0000
719 BURNING SENSATION 1 0.0000
720 SKIN BURNING SENSATION 1 0.0000
721 UNDERDOSE 1 0.0000
722 EPISTAXIS 1 0.0000
723 ASTHENIA 5 0.0000
724 CHRONIC KIDNEY DISEASE 1 0.0000
725 DIABETES MELLITUS 1 0.0000
726 INJECTION SITE BRUISING 1 0.0000
727 CARDIAC FAILURE CONGESTIVE 1 0.0000
728 INFLUENZA LIKE ILLNESS 1 0.0000
729 ARTHRALGIA 5 0.0000
730 MYALGIA 2 0.0000
731 FATIGUE 9 0.0000
732 MUSCULOSKELETAL STIFFNESS 1 0.0000
733 DEVICE ISSUE 1 0.0000
734 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
735 MUSCLE SPASMS 2 0.0000
736 BLOOD GLUCOSE INCREASED 2 0.0000
737 ATRIAL FIBRILLATION 1 0.0000
738 ALOPECIA 2 0.0000
739 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
740 FLUSHING 1 0.0000
741 PAIN 6 0.0000
742 SINUSITIS 1 0.0000
743 HAEMOGLOBIN DECREASED 1 0.0000
744 HAEMORRHAGE 1 0.0000
745 PLATELET COUNT DECREASED 1 0.0000
746 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
747 RHEUMATOID ARTHRITIS 1 0.0000
748 INCORRECT DOSE ADMINISTERED 2 0.0000
749 OEDEMA PERIPHERAL 1 0.0000
750 DRY SKIN 1 0.0000
751 PRODUCT QUALITY ISSUE 1 0.0000
752 VISION BLURRED 1 0.0000
753 MEMORY IMPAIRMENT 1 0.0000
754 PAIN IN EXTREMITY 2 0.0000
755 FALL 2 0.0000
756 URTICARIA 1 0.0000
757 URINARY TRACT INFECTION 1 0.0000
758 DEATH 5 0.0000
759 GAIT DISTURBANCE 1 0.0000
760 PRURITUS 2 0.0000
761 WEIGHT INCREASED 1 0.0000
762 INJECTION SITE PAIN 1 0.0000